Not applicableWithdrawnNCT02421926
What this trial is testing
Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)
Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Asan Medical Center
Showing 20 of 0 results